Forms Processing
PRODUCTS
-
TrialScope Disclose is the industry’s most trusted and comprehensive clinical trial disclosure solution. Simplify, centralize, and gain complete control of your entire global disclosure process from trial planning to results submission, ensuring full transparency and regulatory disclosure compliance at every stage.
-
PHCbi brand's 18.6 cu.ft (528L) ultra-low temperature freezer operates on 220V and features VIP Plus vacuum insulated panels to deliver reliable temperature uniformity throughout the chamber. ENERGY STAR® Certified.
-
Precise, Complete, and Ultimate Detection.
A premium dual energy x-ray inspection system offering outstanding detection of hard-to-find, low density contaminants, in a variety of applications. Available in standard and custom configurations
Detect Hard-to-Find Contaminants
Capable of detecting hard-to-find contaminants in a variety of applications. Offering clarity and precision in complex areas of product inspection.
Enhance Product Quality
Achieves outstanding product quality using advanced levels of foreign body detection of low-density contaminants in overlapping products.
Increase Productivity
Clever design combined with an intuitive user interface to create user-friendly systems that increase uptime and boost productivity.
-
Ensure compliance and improve efficiency by automating your paper-based systems with an integrated EBR system, like MasterControl Manufacturing Excellence.
-
Oral administration remains the most widely used route for the successful delivery of active pharmaceuticals to patients.
WHITE PAPERS AND CASE STUDIES
-
Mobile App And Wearable Integration Collects Longitudinal Data
Get an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
ABB Technology Helps Equip New Zealand With A More Resilient Water And Wastewater Infrastructure
All around the world, issues such as surging energy costs, scarce resources, population growth, and climate change are making securing water in a sustainable way increasingly difficult. Here’s how New Zealand is future-proofing its water system.
-
Rose Research Center Leans On Medrio To Simplify Workflows And Study Design
After experiencing paper processing issues, discover how a company transitioned to digital data collection by using Electronic Data Capture (EDC) and Electronic Patient Reported Outcomes (ePRO) solutions.
-
A Toolbox For An Effective Tech Transfer
As drug development costs rise, companies are embracing digital-first strategies and Pharma 4.0 principles to streamline operations, enhance tech transfer, and accelerate time-to-market through innovation.
-
Site Satisfaction: Influencing Tech Development Strategies
Technology is playing an increasingly important role in clinical trials, helping to improve efficiency, compliance, and data quality. Learn why it’s critical that clinical study technologies are easy to use across sites and fit into the team’s workflows.
-
Reclaim Higher Quality Of Product With Efficient Filtration Strategies
Learn how the implementation of Pall’s Oenoflow™ HS lees filtration system has enabled the Barossa Valley winery to recover higher quality wine from lees more efficiently and economically.
-
Removing Chaos In 3 Steps: A Guide To Planning TMF Migrations
Knowledge and planning are the keys to successful trial master file migrations. Utilize this guide when navigating the most important part of any TMF migration: project scoping and planning.
-
How Optics And Flow Cytometry Are Improving Pancreatic Cancer Treatment
The University of Texas researchers are developing an optical system analyzing cancer cell properties to guide treatments, improving patient outcomes and targeting aggressive cancers like pancreatic.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape
C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.
-
NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.
NEWS
-
Fieldman Introduces Field Service App 2.0 With Real-Time Data Validation4/22/2025
Fieldman, a leader in work order management solutions for utility fieldwork, has released a major update to its field service app.
-
Third Millennium Unveils Multi-Technology Readers Combining Card And QR Code Access In One Device10/13/2025
Third Millennium, a provider of access control solutions and part of HID, announces the launch of new RXQR and RXQRK readers — multi-technology access-control devices that integrate high-security RFID card and QR code credentials into a single, elegant unit.
-
POET Technologies Announces ZKTel As Customer And Collaborator1/3/2024
POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunication and artificial intelligence markets, today announced that Shaoxing ZKTel Equipment Co. (“ZKTel”), which supplies optical computer equipment such as modules and transceivers to Tier 1 companies in China’s datacom and mobile networking industries, is one of the lead customers for POET’s 100G optical engines.
-
Bioxytran Develops A Groundbreaking Treatment To Combat Bird Flu In Egg Laying Chickens Potentially Saving Billions3/12/2025
BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly Pathogenic Avian Influenza (HPAI), commonly known as Bird Flu.
-
Global CDMO Brings Technological Advancements & Significant Capacity To Ocean County, NJ Location9/3/2024
Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.